Rad regulation of CaV1.2 channels controls cardiac fight-or-flight response.

TitleRad regulation of CaV1.2 channels controls cardiac fight-or-flight response.
Publication TypeJournal Article
Year of Publication2022
AuthorsPapa, A, Zakharov, SI, Katchman, AN, Kushner, JS, Chen, B-X, Yang, L, Liu, G, Jimenez, ASanchez, Eisert, RJ, Bradshaw, GA, Dun, W, Ali, SR, Rodriques, A, Zhou, K, Topkara, V, Yang, M, Morrow, JP, Tsai, EJ, Karlin, A, Wan, E, Kalocsay, M, Pitt, GS, Colecraft, HM, Ben-Johny, M, Marx, SO
JournalNat Cardiovasc Res
Volume1
Issue11
Pagination1022-1038
Date Published2022 Nov
ISSN2731-0590
Abstract

Fight-or-flight responses involve β-adrenergic-induced increases in heart rate and contractile force. In the present study, we uncover the primary mechanism underlying the heart's innate contractile reserve. We show that four protein kinase A (PKA)-phosphorylated residues in Rad, a calcium channel inhibitor, are crucial for controlling basal calcium current and essential for β-adrenergic augmentation of calcium influx in cardiomyocytes. Even with intact PKA signaling to other proteins modulating calcium handling, preventing adrenergic activation of calcium channels in Rad-phosphosite-mutant mice (4SA-Rad) has profound physiological effects: reduced heart rate with increased pauses, reduced basal contractility, near-complete attenuation of β-adrenergic contractile response and diminished exercise capacity. Conversely, expression of mutant calcium-channel β-subunits that cannot bind 4SA-Rad is sufficient to enhance basal calcium influx and contractility to adrenergically augmented levels of wild-type mice, rescuing the failing heart phenotype of 4SA-Rad mice. Hence, disruption of interactions between Rad and calcium channels constitutes the foundation toward next-generation therapeutics specifically enhancing cardiac contractility.

DOI10.1038/s44161-022-00157-y
Alternate JournalNat Cardiovasc Res
PubMed ID36424916
PubMed Central IDPMC9681059
Grant ListR01 HL160089 / HL / NHLBI NIH HHS / United States
S10 RR027050 / RR / NCRR NIH HHS / United States
T32 HL120826 / HL / NHLBI NIH HHS / United States
R01 HL151190 / HL / NHLBI NIH HHS / United States
R01 HL113136 / HL / NHLBI NIH HHS / United States
R01 HL155377 / HL / NHLBI NIH HHS / United States
R01 HL136758 / HL / NHLBI NIH HHS / United States
K08 HL153788 / HL / NHLBI NIH HHS / United States
R01 NS110672 / NS / NINDS NIH HHS / United States
R01 HL146149 / HL / NHLBI NIH HHS / United States
P30 CA013696 / CA / NCI NIH HHS / United States
F31 HL158232 / HL / NHLBI NIH HHS / United States
R01 HL121253 / HL / NHLBI NIH HHS / United States
K08 HL151969 / HL / NHLBI NIH HHS / United States
K08 HL146964 / HL / NHLBI NIH HHS / United States
R01 HL140934 / HL / NHLBI NIH HHS / United States
R01 HL152236 / HL / NHLBI NIH HHS / United States
R01 HL138528 / HL / NHLBI NIH HHS / United States